Target Price | $79.55 |
Price | $70.21 |
Potential | 13.30% |
Number of Estimates | 20 |
20 Analysts have issued a price target Coca-Cola 2026 . The average Coca-Cola target price is $79.55. This is 13.30% higher than the current stock price. The highest price target is $85.00 21.07% , the lowest is $70.00 0.30% . | |
A rating was issued by 26 analysts: 22 Analysts recommend Coca-Cola to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Coca-Cola stock has an average upside potential 2026 of 13.30% . Most analysts recommend the Coca-Cola stock at Purchase. |
18 Analysts have issued a sales forecast Coca-Cola 2025 . The average Coca-Cola sales estimate is $48.2b . This is 2.69% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $48.6b 3.70% , the lowest is $47.3b 0.96% .
This results in the following potential growth metrics:
2024 | $47.1b | 2.86% |
---|---|---|
2025 | $48.2b | 2.32% |
2026 | $50.7b | 5.32% |
2027 | $53.6b | 5.73% |
2028 | $55.7b | 3.83% |
13 Analysts have issued an Coca-Cola EBITDA forecast 2025. The average Coca-Cola EBITDA estimate is $16.1b . This is 25.52% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $16.6b 28.88% , the lowest is $14.5b 12.40% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $12.1b | 8.60% |
---|---|---|
2025 | $16.1b | 33.20% |
2026 | $17.4b | 8.02% |
2027 | $18.9b | 8.49% |
2028 | $20.3b | 7.33% |
2024 | 25.76% | 11.14% |
---|---|---|
2025 | 33.53% | 30.18% |
2026 | 34.39% | 2.56% |
2027 | 35.29% | 2.62% |
2028 | 36.48% | 3.37% |
8 Coca-Cola Analysts have issued a net profit forecast 2025. The average Coca-Cola net profit estimate is $12.7b . This is 17.70% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $13.0b 20.13% , the lowest is $12.0b 11.72% .
This results in the following potential growth metrics and future Net Margins:
2024 | $10.6b | 0.77% |
---|---|---|
2025 | $12.7b | 19.40% |
2026 | $13.8b | 8.87% |
2027 | $14.9b | 8.13% |
2028 | $16.4b | 9.59% |
2024 | 22.59% | 3.53% |
---|---|---|
2025 | 26.36% | 16.69% |
2026 | 27.25% | 3.38% |
2027 | 27.87% | 2.28% |
2028 | 29.41% | 5.53% |
8 Analysts have issued a Coca-Cola forecast for earnings per share. The average Coca-Cola EPS is $2.95 . This is 18.00% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.01 20.40% , the lowest is $2.80 12.00% .
This results in the following potential growth metrics and future valuations:
2024 | $2.46 | 0.40% |
---|---|---|
2025 | $2.95 | 19.92% |
2026 | $3.21 | 8.81% |
2027 | $3.47 | 8.10% |
2028 | $3.80 | 9.51% |
Current | 28.08 | 11.85% |
---|---|---|
2025 | 23.81 | 15.22% |
2026 | 21.87 | 8.15% |
2027 | 20.22 | 7.54% |
2028 | 18.45 | 8.75% |
Based on analysts' sales estimates for 2025, the Coca-Cola stock is valued at an EV/Sales of 7.01 and an P/S ratio of 6.28 .
This results in the following potential growth metrics and future valuations:
Current | 7.20 | 11.98% |
---|---|---|
2025 | 7.01 | 2.64% |
2026 | 6.66 | 5.05% |
2027 | 6.29 | 5.42% |
2028 | 6.06 | 3.69% |
Current | 6.44 | 9.81% |
---|---|---|
2025 | 6.28 | 2.62% |
2026 | 5.96 | 5.05% |
2027 | 5.64 | 5.42% |
2028 | 5.43 | 3.69% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jun 09 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 21 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Feb 28 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 13 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jun 09 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 21 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Feb 28 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.